Treatment of Severe Infections With Mesenchymal Stem Cells
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- 60
Summary
- Conditions
- Septic Shock
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Patients hospitalized in recovery unit and having a very severe septic shock with community origin (? 2 organ failures other than hemodynamic) since less than 12 hours, will receive 10^6/kg heterologous mesenchymal stem cells in 250 ml albumin 4%, infused for 30 minutes in central venous line or 250...
Patients hospitalized in recovery unit and having a very severe septic shock with community origin (? 2 organ failures other than hemodynamic) since less than 12 hours, will receive 10^6/kg heterologous mesenchymal stem cells in 250 ml albumin 4%, infused for 30 minutes in central venous line or 250 ml albumin 4% alone.
Tracking Information
- NCT #
- NCT02883803
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Sébastien GIBOT Service de Réanimation Médicale, Hôpital Central, 54035, Nancy Cedex
Get Well Soon